Consumer Healthcare

Haleon Forecasting 4% To 6% Revenue Growth this Year

Haleon, the world's biggest standalone consumer health business, has forecast 4% to 6% organic revenue growth in 2023.

GSK Announces Board And Committee Changes

Global biopharma company GSK has announced a number of changes to its board and committees, which are set to take effect immediately following the demerger...

GSK Spins Off Haleon In Biggest European Listing For A Decade

GSK has officially spun off its consumer health business, Haleon, in the biggest listing in Europe for more than a decade.

Pfizer Set To Exit GSK's Consumer Health Arm After Spin-Off

Pfizer plans to exit its 32% stake in Haleon, its consumer health joint venture with British drugmaker GSK, after the business is spun off as an independen...

GSK Says Consumer Arm Spin-Off 'On Track', Stands By Forecasts

Britain's GSK beat analyst expectations for its first-quarter results on Wednesday and stood by its forecasts for 2022, ahead of the planned listing of its...

Former Tesco Boss Lewis To Chair GSK Health Spin-Off

GlaxoSmithKline has named former Tesco chief executive Dave Lewis as non-executive chair designate of a new Consumer Healthcare company set to be created f...

Johnson & Johnson To Split Into Two Companies

Johnson & Johnson will separate its consumer health business into a new publicly traded company and is aiming to complete the separation in 18 to 24 mo...

Britain's GSK Lifts Outlook After 'Better-Than-Expected' Q3 Results

Britain's GSK raised its annual profit outlook after better-than-expected third-quarter results on strong sales of key drugs and cost cutting ahead of...